SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-003467
Filing Date
2015-05-07
Accepted
2015-05-06 18:55:22
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ptla-10q_20150331.htm 10-Q 1405366
2 EX-31.1 ptla-ex311_20150331150.htm EX-31.1 8993
3 EX-31.2 ptla-ex312_20150331151.htm EX-31.2 9019
4 EX-32.1 ptla-ex321_20150331152.htm EX-32.1 7780
  Complete submission text file 0001564590-15-003467.txt   6702046

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ptla-20150331.xml EX-101.INS 1057786
6 XBRL TAXONOMY EXTENSION SCHEMA ptla-20150331.xsd EX-101.SCH 39927
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ptla-20150331_cal.xml EX-101.CAL 33785
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ptla-20150331_def.xml EX-101.DEF 105061
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptla-20150331_lab.xml EX-101.LAB 281511
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptla-20150331_pre.xml EX-101.PRE 211696
Mailing Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080
Business Address 270 EAST GRAND AVENUE, SUITE 22 SOUTH SAN FRANCISCO CA 94080 650-244-6864
PORTOLA PHARMACEUTICALS INC (Filer) CIK: 0001269021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35935 | Film No.: 15838806
SIC: 2834 Pharmaceutical Preparations